BioMarin reports five-year Pompe disease data showing durable motor function

A BioMarin combination therapy helped adults with late-onset Pompe disease maintain walking distance over five years of continuous therapy. Respiratory function remained relatively stable, with no new...

本文内容来自外部来源，点击「继续访问」将跳转到原始发布站点。